Bio Key International Inc
BKYI Nasdaq· Services-Prepackaged Software
Last close · Oct 23, 2026
$3.39
KIRA · Stoqly’s AI analyst, in plain words
- Bio Key International Inc had $5.9M of revenue in fiscal 2025, down 14.3% on the year before. Over five years, revenue changed +15.9% a year on average.
- Its operating margin was −115.0%, down 57.1 pts: of every 100 in sales, about −115 is left after running the business.
- Bio Key International Inc lost $7.2M in fiscal 2025.
- Free cash flow was −$4.7M in fiscal 2025, −78.8% of revenue.
Market cap
—
P/E
—
Revenue
$5.9M
Net income
−$7.2M
Free cash flow
−$4.7M
Operating margin
−115.0%
Bio Key International Inc in 30 seconds · fiscal 2025
Are sales growing?
−14.3%
No. Sales fell 14.3% last year.
Does it make a profit?
−120.6%
No. It lost money last year.
Does profit turn into cash?
−78.8%
No. It spent more cash than it brought in.
How healthy are the accounts?
2 / 7
Weak. It passes 2 of 7 health tests.
What Bio Key International Inc does
No business description yet.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K · Jun 12, 2026
- Legal name
- BIO KEY INTERNATIONAL INC
- CIK
- 0001019034
Bio Key International Inc · BKYI
Results and finances
The last 5 fiscal years. Amounts in USD.
| Fiscal year | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Sales and profit | |||||
| Revenue | $5.1M | $7.0M | $7.8M | $6.9M | $5.9M |
| Revenue growth | 80.3% | 37.3% | 10.5% | −10.6% | −14.3% |
| Gross margin | 67.3% | 65.2% | 18.5% | 81.4% | 76.9% |
| Operating margin | −96.6% | −141.4% | −113.8% | −57.9% | −115.0% |
| Net income | −$5.1M | −$11.9M | −$8.5M | −$4.3M | −$7.2M |
| Net margin | −99.0% | −169.6% | −109.9% | −62.1% | −120.6% |
| Diluted EPS | −$0.65 | — | — | — | — |
| Cash | |||||
| Cash from operations | −$9.0M | −$6.2M | −$3.8M | −$2.9M | −$4.7M |
| Capital expenditure | $0.0M | $0.1M | $0.0M | $0.0M | $0.0M |
| Free cash flow | −$9.0M | −$6.3M | −$3.8M | −$2.9M | −$4.7M |
| FCF margin | −176.4% | −89.9% | −48.9% | −42.2% | −78.8% |
| Share count change | 65.8% | — | — | — | — |
| Debt and strength | |||||
| Cash and short-term investments | $7.8M | $2.6M | $0.5M | $0.4M | $2.7M |
| Debt incl. finance leases | $0.0M | $3.0M | $0.3M | $0.0M | — |
| Shareholders' equity | $15.6M | $5.3M | $1.1M | $3.8M | $5.1M |
| Current ratio | 7.0x | 1.6x | 0.8x | 0.4x | 1.5x |
| Interest coverage | −274.6x | −945.1x | −40.4x | −22.8x | −112.3x |
| Returns and quality | |||||
| Return on capital | −49.7% | −137.3% | −792.6% | −93.8% | — |
| Return on equity | −28.2% | −113.9% | −267.8% | −177.9% | −161.2% |
| Return on tangible equity | −38.8% | −336.6% | — | −160.8% | −167.4% |
| Piotroski F-score | 3 | 2 | 3 | 4 | 2 |
| Altman Z'' | −9.0 | −36.4 | −103.9 | −53.3 | −56.3 |
Insiders bought, 12 months
$0.0M
0 insiders
Insiders sold, 12 months
$0.0M
0 insiders
Of sales under plans
—
$0.0M
How to read these numbers
- Revenue:
- Total sales reported in the income statement.
- Operating margin:
- Operating income as a share of revenue.
- Net income:
- Profit after all expenses, interest and tax.
- Free cash flow:
- Cash from operations minus capital spending.
- Net debt / EBITDA:
- Years of EBITDA needed to pay off net debt. Below zero means more cash than debt.
- Return on capital:
- After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Bio Key International Inc · BKYI
Charts and comparison
Ten years at a glance, and how it stacks up against similar companies.
Revenue
Net income
Margins, % of revenue
Cash vs debt (incl. leases)
Free cash flow
Dividends and buybacks
KIRA
At $3.39 a share, the company is worth —.
Source: SEC EDGAR XBRL filings (CIK 0001019034). Data updated October 24, 2026. For information only — not investment advice. Check the original filings before relying on any figure.